IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Minnetonka, Minnesota.
Frequently asked questions
What sector does IMRIS Inc. (IMRSQ) operate in?
IMRIS Inc. belongs to the Healthcare sector and operates in the Medical Devices industry.
What is IMRIS Inc. (IMRSQ) current stock price?
As of the latest data, IMRIS Inc. stock price is $0.00, with a previous close of $0.00.
Does IMRIS Inc. (IMRSQ) pay dividends?
No. IMRIS Inc. does not pay a dividend.
What is IMRIS Inc. (IMRSQ) beta (volatility) score?
IMRIS Inc. has a beta of 50.987, indicating very high volatility compared to the market.
